Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2025	Jun. 30, 2025
Current assets:
Cash and cash equivalents		$ 2,424.7	$ 3,347.8
Short-term marketable securities	[1]	45.7	4,498.8
Accounts receivable, net of allowance for doubtful accounts of $47.5 and $47.1, respectively		3,408.5	3,579.1
Other current assets		1,083.1	840.8
Total current assets before funds held for clients		6,962.0	12,266.5
Funds held for clients		67,510.1	30,985.7
Total current assets		74,472.1	43,252.2
Property, plant and equipment, net		622.7	655.4
Operating lease right-of-use asset		405.7	374.1
Deferred contract costs		3,109.1	3,154.1
Other assets		1,113.1	1,057.0
Goodwill		3,294.2	3,273.5
Intangible assets, net		1,622.5	1,603.0
Total assets		84,639.4	53,369.3
Current liabilities:
Accounts payable		143.1	169.1
Accrued expenses and other current liabilities		2,478.1	3,092.4
Accrued payroll and payroll-related expenses		721.3	973.1
Dividends payable		680.5	620.6
Short-term deferred revenues		261.7	262.8
Obligations under reverse repurchase agreements	[1]	45.8	38.4
Obligations under commercial paper borrowings		0.0	4,769.5
Income taxes payable		197.3	9.1
Total current liabilities before client funds obligations		4,527.8	9,935.0
Client funds obligations		67,613.7	31,343.3
Total current liabilities		72,141.5	41,278.3
Long-term debt		3,976.4	3,974.7
Operating lease liabilities		347.6	321.2
Other liabilities		1,051.2	1,058.3
Deferred income taxes		349.5	163.6
Long-term deferred revenues		380.2	385.2
Total liabilities		78,246.4	47,181.3
Commitments and contingencies (Note 14)
Stockholders' equity:
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none		0.0	0.0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at December 31, 2025 and June 30, 2025; outstanding, 403.0 and 405.3 shares at December 31, 2025 and June 30, 2025, respectively		63.9	63.9
Capital in excess of par value		2,936.8	2,788.3
Retained earnings		25,992.6	25,240.6
Treasury stock - at cost: 235.7 and 233.4 shares at December 31, 2025 and June 30, 2025, respectively		(21,960.6)	(21,021.4)
Accumulated other comprehensive income/(loss)		(639.7)	(883.4)
Total stockholders’ equity		6,393.0	6,188.0
Total liabilities and stockholders’ equity		$ 84,639.4	$ 53,369.3

[1] As of December 31, 2025, $45.7 million of short-term marketable securities and $0.1 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements. As of June 30, 2025, $38.4 million of short-term marketable securities have been pledged as collateral under the Company's reverse repurchase agreements (see Note 10).